FTI Consulting, Inc. announces the expansion of its Health Solutions practice with the addition of managing directors Gaurica Chacko, Michael Kleinmann and Rick van der Vegte.
“Gaurica, Michael and Rick bring deep industry expertise and will enhance our ability to help clients across the healthcare and life sciences sectors achieve their strategic and operational objectives at a time when resiliency and transformation have never been more critical,” said Charles Overstreet, global leader of the Health Solutions practice at FTI Consulting. “Their appointments represent our continued investment in our Health Solutions business, and I am excited to welcome them to the team.”
Based in Los Angeles, Ms. Chacko has more than 20 years of experience in the management consulting and life sciences industries, where she has held several senior-level roles advising on portfolio optimization, strategic planning and business development strategies. Ms. Chacko’s areas of expertise span late-stage development through commercialization, including research and development, clinical and commercial strategy, performance improvement, and regulation and compliance across global biopharmaceutical, medical device and diagnostic, and healthcare technology companies.
Based in Milwaukee, Mr. Kleinmann has nearly 25 years of consulting experience and specializes in assisting commercial and government healthcare and life sciences entities with digital health and technology transformations. He has led numerous cross-functional initiatives, including IT business cases and investment plans, vendor assessments and system selections, IT and innovation assessments and strategies, IT operating and governance model redesigns, platform strategies, digital health strategies, data monetization strategies and enterprise-level technology transformation programs.
Based in New York, Mr. Van der Vegte has more than 10 years of global supply chain and operations management experience and will lead the Supply Chain Management offering within FTI Consulting’s Healthcare and Life Sciences industry group. He specializes in end-to-end supply chain design from strategy – with focus on service design, performance improvement and technology strategy – to mergers and acquisitions advisory. Having worked with many stakeholders along the connected value chain, Mr. Van der Vegte has extensive experience in commercial supply chain operations for emerging therapies, vaccine operations and medical device distribution.